Point72 Asset Management, L.P.
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,921,062
+$1,574,648 QoQ
Shares Held
590,877
+39.0% QoQ
Ownership
0.472%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,298,297 across 187 Biotechnology names. ARQT ranks #50 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in ARQT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,921,062 | 590,877 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,346,414 | 425,152 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $20,825,658 | 1,485,425 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,988,675 | 830,478 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $24,426,561 | 1,753,522 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,272,789 | 244,386 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $1,034,569 | 320,300 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $16,332,924 | 1,103,576 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $72,336,643 | 3,785,277 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,352,154 | 1,987,431 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $32,700,571 | 1,697,849 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $54,840,230 | 2,644,177 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $47,591,436 | 1,992,107 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,462,756 | 896,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,708,949 | 439,300 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,619,376 | 875,200 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,267,400 | 43,256 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||